Mercer Global Advisors
ZBIO

Mercer Global Advisors’s Zenas BioPharma ZBIO Stock Holding History

Mercer Global Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Buy
+1,093
New +$21.7K ﹤0.01% 4647

Other funds holding ZBIO

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mercer Global Advisors's ZBIO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 1,093 shares worth $27.7K. The stake represents ﹤0.01% of the portfolio and ranks #4647 among its holdings.

114 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Mercer Global Advisors held 1,093 shares of Zenas BioPharma worth $27.7K as of Q2 2026.
  • Zenas BioPharma was a new Mercer Global Advisors position in Q2 2026.
  • Zenas BioPharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4647 holding.
  • 114 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.